Rietveld refinement in the routine quantitative analysis of famotidine polymorphs

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 3, 2010, Pages 572-576

  Német, Zoltán ^a   Sajó, István ^b   Demeter, Ádám ^a  

^a GEDEON RICHTER LTD   (Hungary)

^b CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Famotidine; Quantitative analysis; Rietveld refinement; Transmission; X ray powder diffraction

Indexed keywords

FAMOTIDINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; RELIABILITY; X RAY POWDER DIFFRACTION;

CRYSTALLIZATION; EVALUATION STUDIES AS TOPIC; FAMOTIDINE; LEAST-SQUARES ANALYSIS; X-RAY DIFFRACTION;

EID: 70350604436     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.09.017     Document Type: Article

References (14)

1. Stephenson G.A., Forbes R.A., and Reutzel-Edens S.-M. Characterization of the solid state: quantitative issues. Adv. Drug Deliv. Rev. 48 (2001) 67-90
2. Raw A.S., Furness M.S., Gill D.S., Adams R.C., Holcombe Jr. F.O., and Yu L.X. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv. Drug Deliv. Rev. 56 (2004) 397-414
3. Food and Drug Administration, Center for Drug Evaluation and Research, and Guidance for Industry. ANDAs: Pharmaceutical Solid Polymorphism: Chemistry, Manufacturing, and Controls Information (2007). http://www.fda.gov/cder/guidance/index.htm
4. Bernstein J. Polymorphism of Molecular Crystals (2002), Clarendon, Oxford pp. 297-307
5. Cabri W., Ghetti P., Pozzi G., and Alpegiani M. Polymorphisms and patent, market, and legal battles: cefdinir case study. Org. Process Res. Dev. 11 (2007) 64-72
6. Hegedu{combining double acute accent}s B., Bod P., Harsányi K., Péter I., Kálmán A., and Párkányi L. Comparison of the polymorphic modifications of famotidine. J. Pharm. Biomed. Anal. 7 (1989) 563-569
7. Német Z., Csonka Kis G., Pokol G., and Demeter A. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study. J. Pharm. Biomed. Anal. 49 (2009) 338-346
8. Madsen I.C., and Scarlett N.V.Y. Quantitative phase analysis. In: Dinnebier R.E., and Billinge S.J.L. (Eds). Powder Diffraction: Theory and Practice (2008), RCS Publishing, Cambridge 298-331
9. McCusker L.B., Von Dreele R.B., Cox D.E., Louer D., and Scardi P. Rietveld refinement guidelines. J. Appl. Crystallogr. 32 (1999) 36-50
10. Iyengar S.S., Phadnis N.V., and Suryanarayanan R. Quantitative analysis of complex pharmaceutical mixtures by the Rietveld method. Powder Diffr. 16 (2001) 20-24
11. Yamamura S., Takahira R., and Momose Y. Crystallization kinetics of amorphous griseofulvin by pattern fitting procedure using X-ray diffraction data. Pharm. Res. 24 (2007) 880-887
12. Rodrigues-Carvajal J. Reference guide for the computer program Fullprof (1996), Laboratoire Léon Brilluin CEA-CNRS, Saclay, France
13. Ferenczy G., Párkányi L., Ángyán J.G., Kálmán A., and Hegedu{combining double acute accent}s B. Crystal and electronic structure of two modifications of famotidine. An experimental and theoretical study. J. Mol. Struct. (Theochem.) 503 (2000) 73-79
14. Chung F.H. Quantitative interpretation of X-ray diffraction patterns of mixtures. I. Matrix-flushing method for quantitative multicomponent analysis. J. Appl. Crystallogr. 7 (1974) 519-525